购物车
0
有库存
HIT218852180
 sdf 文件
结构编辑
类似物检索
HIT218852180
  • HIT ID:HIT218852180
  • Cas No:2635953-17-0
  • 常用名:ABI-231 HCl
  • IUPAC:3-[5-(3,4,5-trimethoxybenzoyl)-1H-imidazol-2-yl]-1H-indole hydrochloride
    IUPAC:3-[5-(3,4,5-trimethoxybenzoyl)-1H-imidazol-2-yl]-1H-indole hydrochloride
  • InChI key:XJDKAFZMXMMMKD-UHFFFAOYSA-N
  • 分子式:C21H20ClN3O4
  • 分子量:413.86
  • 氢键供体数 (HBD):
  • 氢键受体数 (HBA):
  • LogP:
  • SMILES:Cl.COc1cc(cc(OC)c1OC)C(=O)c1cnc([nH]1)-c1c[nH]c2ccccc12
    SMILES:Cl.COc1cc(cc(OC)c1OC)C(=O)c1cnc([nH]1)-c1c[nH]c2ccccc12
  • ABI-231 is a potent, orally bioavailable tubulin inhibitor that interacts with the colchicine binding site and is currently undergoing clinical trials for prostate cancer. ABI-231, has an average IC50 = 5.2 nM against panels of melanoma and prostate cancer cell lines, is orally bioavailable, and strongly suppress melanoma tumors in vivo. ABI-231 holds great promise as a new generation of orally available tubulin inhibitor.
市场产品/服务共显示1个结果
  • 供应商
    TargetMolSC
    规格
    货期
    6-8周
    纯度
    -
    ¥ 10,600.00
    1

寻找合适的化合物库

您无法确定哪种化合物库最适合您的项目?或者您需要定制解决方案?Anymole随时为您提供帮助。
电话:400820-0310
合作:info@screeningcompound.com
技术支持:tech@screeningcompound.com
客服:service@screeningcompound.com
TargetMol | Target Loading
正在加载 ~